Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia Savitha VaratharajanAjay AbrahamPoonkuzhali Balasubramanian Pharmacogenetics 05 May 2012 Pages: 1577 - 1586
Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus Mateusz KurzawskiKrzysztof DziewanowskiMarek Droździk Pharmacogenetics Open access 09 May 2012 Pages: 1587 - 1594
Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects Susan E. ShoafSeong Ryul KimSuresh Mallikaarjun Pharmacokinetics and Disposition 15 May 2012 Pages: 1595 - 1603
Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans Tsutomu KotegawaKimiko TsutsumiKyoichi Ohashi Pharmacokinetics and Disposition 30 May 2012 Pages: 1605 - 1610
Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO Luther GwazaJohn GordonAlfredo García-Arieta Pharmacokinetics and Disposition 21 September 2012 Pages: 1611 - 1618
Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden B. GrundmarkH. GarmoL. Holmberg Pharmacoepidemiology and Prescription 05 May 2012 Pages: 1619 - 1630
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data Kamilla ØstergaardJesper HallasDavid Gaist Pharmacoepidemiology and Prescription 11 May 2012 Pages: 1631 - 1637
Complementary or alternative? Patterns of complementary and alternative medicine (CAM) use among Finnish children Sanna M. SiponenRiitta S. AhonenKatri P. Hämeen-Anttila Pharmacoepidemiology and Prescription 10 May 2012 Pages: 1639 - 1645
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders Valentino ContiAntonio LoraCorrado Barbui Pharmacoepidemiology and Prescription 10 May 2012 Pages: 1647 - 1655
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia Asia N. RashedAntje NeubertIan C. K. Wong Pharmacoepidemiology and Prescription 30 May 2012 Pages: 1657 - 1666
Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study Paulo Roque Obreli-NetoAlessandro NobiliRoberto Kenji Nakamura Cuman Pharmacoepidemiology and Prescription 30 May 2012 Pages: 1667 - 1676
Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers Can-Jun RuanDong-Yang LiuPei Hu Short Communication 15 May 2012 Pages: 1677 - 1680
Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! Dominique Hillaire-BuysJean-Luc FailliePierre Petit Letter to the Editors 11 May 2012 Pages: 1681 - 1683
Bevacizumab treatment in hereditary hemorrhagic teleangiectasia Sebastian FöllnerMichael IbeJens Schreiber Letter to the Editors 30 May 2012 Pages: 1685 - 1686
Interaction between amorolfine and acenocoumarol José A. Morales-MolinaAnna Fayet-PérezM. Angustias Molina-Arrebola Letter to the Editors 31 May 2012 Pages: 1687 - 1688
Erratum to: Effects of codeine on pregnancy outcome: results from a large population-based cohort study Kateřina Nezvalová-HenriksenOlav SpigsetHedvig Nordeng Erratum 24 October 2012 Pages: 1689 - 1690